{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:36:37Z","timestamp":1794105397149,"version":"4.8.0"},"reference-count":530,"publisher":"American Chemical Society (ACS)","issue":"19","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["TMU107-AE1-B33"],"award-info":[{"award-number":["TMU107-AE1-B33"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["107-2113-M-038-001"],"award-info":[{"award-number":["107-2113-M-038-001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2113-M-038-005"],"award-info":[{"award-number":["108-2113-M-038-005"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2320-B-038-010-MY2 (2-1)"],"award-info":[{"award-number":["108-2320-B-038-010-MY2 (2-1)"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Chem."],"published-print":{"date-parts":[[2020,10,8]]},"DOI":"10.1021\/acs.jmedchem.9b01033","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T07:52:08Z","timestamp":1591084328000},"page":"10533-10593","source":"Crossref","is-referenced-by-count":64,"title":["Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye"],"prefix":"10.1021","volume":"63","author":[{"given":"Kuei-Ju","family":"Cheng","sequence":"first","affiliation":[{"name":"School of Pharmacy, College of Pharmacy, Taipei Medical University, 250 Wuxing Street, Taipei 11031, Taiwan"},{"name":"Department of Pharmacy, Taipei Municipal Wanfang Hospital, Taipei Medical University, No. 111, Section 3, Xing-Long Road, Taipei 11696, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Ming","family":"Hsieh","sequence":"additional","affiliation":[{"name":"School of Pharmacy, College of Pharmacy, Taipei Medical University, 250 Wuxing Street, Taipei 11031, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Nepali","sequence":"additional","affiliation":[{"name":"School of Pharmacy, College of Pharmacy, Taipei Medical University, 250 Wuxing Street, Taipei 11031, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3775-6405","authenticated-orcid":true,"given":"Jing-Ping","family":"Liou","sequence":"additional","affiliation":[{"name":"School of Pharmacy, College of Pharmacy, Taipei Medical University, 250 Wuxing Street, Taipei 11031, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"key":"ref1\/cit1a","doi-asserted-by":"publisher","DOI":"10.1016\/S0070-2153(10)90010-0"},{"key":"ref1\/cit1b","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2014.10.006"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14024"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1106"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3745"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/734527"},{"key":"ref6\/cit6","unstructured":"Blindness and Vision Impairment; World Health Organization, 2019; https:\/\/www.who.int\/blindness\/en\/ (accessed 2019-03-29)."},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2016.03.104"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14328"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.195920"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0671-0"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-306778"},{"key":"ref12\/cit12","first-page":"3","volume":"169","author":"Patel U.","year":"2018","journal-title":"CADTH Issues in Emerging Health Technologies"},{"key":"ref13\/cit13","unstructured":"ReSure Sealant; Ocular Therapeutix: Bedford, MA, 2020; https:\/\/www.ocutx.com\/products\/resure-sealant\/ (accessed 2020-03-05)."},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.04.017"},{"key":"ref15\/cit15a","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2017.0079"},{"key":"ref15\/cit15b","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6071"},{"key":"ref15\/cit15c","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133149"},{"key":"ref15\/cit15d","doi-asserted-by":"publisher","DOI":"10.4103\/2230-973X.100040"},{"key":"ref15\/cit15e","doi-asserted-by":"publisher","DOI":"10.5650\/jos.59.423"},{"key":"ref15\/cit15f","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600680619"},{"key":"ref15\/cit15g","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600620936"},{"key":"ref15\/cit15h","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2005.07.005"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.119.256933"},{"key":"ref17\/cit17a","doi-asserted-by":"publisher","DOI":"10.1016\/S0142-9612(99)00148-9"},{"key":"ref17\/cit17b","doi-asserted-by":"publisher","DOI":"10.4028\/www.scientific.net\/KEM.377.195"},{"key":"ref18\/cit18a","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0b013e31827a7a07"},{"key":"ref18\/cit18b","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2010.01.113"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2012.01.019"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2004.10.006"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/238351"},{"key":"ref22\/cit22","unstructured":"Ophthalmic Drug Delivery; Frederick Furness Publishing Ltd: Lewes, UK, 2019; https:\/\/www.ondrugdelivery.com\/publications\/63\/ForSight.pdf\/ (accessed 2019-01-24)."},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00625"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00423"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1021\/ml5005206"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2208"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b01684"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00425"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-019-0303-9"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00271"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2006.05.001"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2007"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0783"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(80)90015-6"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(13)70145-1"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1038\/ng1873"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.116.8.1082"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.10.1357"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31550-2"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.222551899"},{"key":"ref41\/cit41a","first-page":"443","volume":"40","author":"Okubo A.","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref41\/cit41b","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(85)33993-3"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1038\/nm1010-1107"},{"key":"ref43\/cit43a","unstructured":"aMacular Degeneration Treatments; American Macular Degeneration Foundation: Northampton, MA. 2019; https:\/\/www.macular.org\/treatments\/ (accessed 2019-05-15)."},{"key":"ref43\/cit43b","unstructured":"bAnti-VEGF Treatment; Royal National Institute of Blind People: London, 2019; https:\/\/www.rnib.org.uk\/eye-health\/eye-conditions\/anti-vegf-treatment\/ (accessed 2019-01-15)."},{"key":"ref44\/cit44a","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102673"},{"key":"ref44\/cit44b","unstructured":"bAflibercept; DrugBank, 2019; https:\/\/www.drugbank.ca\/drugs\/DB08885\/ (accessed 2019-01-17)."},{"key":"ref45\/cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009300.pub2"},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2011.07.019"},{"key":"ref47\/cit47a","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4943(02)00005-5"},{"key":"ref47\/cit47b","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.2004.tb00002.x"},{"key":"ref47\/cit47c","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21792"},{"key":"ref48\/cit48a","doi-asserted-by":"publisher","DOI":"10.1172\/JCI105889"},{"key":"ref48\/cit48b","doi-asserted-by":"publisher","DOI":"10.1021\/bi982291i"},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2018.1448060"},{"key":"ref50\/cit50a","doi-asserted-by":"publisher","DOI":"10.1038\/nature11861"},{"key":"ref50\/cit50b","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2017.05.012"},{"key":"ref51\/cit51","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.18-24426"},{"key":"ref52\/cit52","unstructured":"Macular Degeneration; International Society for Stem Cell Research. 2019; https:\/\/www.closerlookatstemcells.org\/stem-cells-medicine\/macular-degeneration\/ (accessed 2019-03-17)."},{"key":"ref53\/cit53","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-019-00017-8"},{"key":"ref54\/cit54","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2017.1356817"},{"key":"ref55\/cit55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802268"},{"key":"ref56\/cit56","unstructured":"European Commission Approves Spark Therapeutics; Spark Therapeutics, 2019; http:\/\/ir.sparktx.com\/news-releases\/news-release-details\/european-commission-approves-spark-therapeutics-luxturnar\/ (accessed 2019-03-19)."},{"key":"ref57\/cit57","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-018-00016-1"},{"key":"ref58\/cit58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.02.018"},{"key":"ref59\/cit59","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2019.05.038"},{"key":"ref60\/cit60","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2006.17.167"},{"key":"ref61\/cit61","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00345-1"},{"key":"ref62\/cit62","unstructured":"Avalanche Biotechnologies, Inc., Announces Positive Top-Line Phase 2a Results for Ava-101 in Wet Age-Related Macular Degeneration; Adverum Biotechnologies, 2019; http:\/\/investors.adverum.com\/news-releases\/newsrelease-details\/avalanche-biotechnologies-inc-announces-positivetop-line-phase\/ (accessed 2019-12-10)."},{"key":"ref63\/cit63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.11.016"},{"key":"ref64\/cit64","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-0016(16)33058-1"},{"key":"ref65\/cit65","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30979-0"},{"key":"ref66\/cit66","unstructured":"Regenxbio Programs; REGENXBIO: Rockville, MD, 2020; http:\/\/ir.regenxbio.com\/news-releases\/news-release-details\/regenxbio-reports-continued-progress-across-programs-year-end-0\/ (accessed 2019-12-14)."},{"key":"ref67\/cit67","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2016.117"},{"key":"ref68\/cit68","unstructured":"ClinicalTrials.gov; National Institutes of Health: Bethesda, MD, 2020; https:\/\/clinicaltrials.gov\/ (accessed 2020-01-10)."},{"key":"ref69\/cit69","unstructured":"Update on Clinical Trials for Macular Degeneration; BrightFocus Foundation: Clarksburg, MD, 2019; https:\/\/www.brightfocus.org\/macular\/article\/update-clinical-trials-macular\/ (accessed 2010-03-09)."},{"key":"ref70\/cit70","unstructured":"Graybug Vision Initiates Phase 1\/2 Trial of GB-102 for Wet Age-related Macular Degeneration; Graybug Vision, Inc.: Redwood City, CA, 2017; https:\/\/graybug.com\/graybug-vision-initiates-phase-12-trial-of-gb-102-for-wet-age-related-macular-degeneration\/ (accessed 2019-02-21)."},{"key":"ref71\/cit71","unstructured":"An Oral Drug for Treatment of AMD?; Bryn Mawr Communications LLC: Wayne, PA, 2019; http:\/\/retinatoday.com\/2016\/08\/an-oral-drug-for-treatment-of-amd\/ (accessed 2019-02-21)."},{"key":"ref72\/cit72","unstructured":"X-82 to Treat Age-related Macular Degeneration.ClinicalTrials.gov; National Institutes of Health: Bethesda, MD, 2018; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02348359\/ (accessed Jan 30, 2019)."},{"key":"ref73\/cit73","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13794"},{"key":"ref74\/cit74","unstructured":"Abicipar; Molecular Partners, 2019; https:\/\/www.molecularpartners.com\/our-products\/abicipar\/ (accessed 2019-01-13)."},{"key":"ref75\/cit75","unstructured":"OPT 302; Adis International Ltd, 2019; https:\/\/adisinsight.springer.com\/drugs\/800043497 (accessed 2019-02-19)."},{"key":"ref76\/cit76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.10.010"},{"key":"ref77\/cit77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.06.002"},{"key":"ref78\/cit78","unstructured":"Ophthotech Announces Results from Third Phase 3 Trial of Fovista in Wet Age-Related Macular Degeneration; Ophthotech, 2018; https:\/\/investors.ivericbio.com\/news-releases\/news-release-details\/ophthotech-announces-results-third-phase-3-trial-fovistar-wet\/ (accessed 2018-05-26)."},{"key":"ref79\/cit79","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1221"},{"key":"ref80\/cit80","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201505889"},{"key":"ref81\/cit81","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.2137.2137"},{"key":"ref82\/cit82","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2019.1575358"},{"key":"ref83\/cit83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.09.044"},{"key":"ref84\/cit84","first-page":"1251","volume":"51","author":"Cousins S. W.","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref85\/cit85","unstructured":"Lampalizumab\u2014Genentech; Adis International Ltd, 2019; https:\/\/adisinsight.springer.com\/drugs\/800024383 (accessed 2019-01-15)."},{"key":"ref86\/cit86","unstructured":"Tesidolumab\u2014MorphoSys; Adis International Ltd, 2019; https:\/\/adisinsight.springer.com\/drugs\/800032650 (accessed Jan 17, 2019)."},{"key":"ref87\/cit87","doi-asserted-by":"publisher","DOI":"10.4103\/jmedsci.jmedsci_115_16"},{"key":"ref88\/cit88","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318217369e"},{"key":"ref89\/cit89","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.11.023"},{"key":"ref90\/cit90","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-306972"},{"key":"ref91\/cit91","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M809654200"},{"key":"ref92\/cit92","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.265"},{"key":"ref93\/cit93","first-page":"92","volume":"9","author":"Kuwada S. K.","year":"2007","journal-title":"Curr. Opin. Mol. Ther."},{"key":"ref94\/cit94","unstructured":"Sonepcizumab\u2014Lpath;Adis International Ltd. 2018; https:\/\/adisinsight.springer.com\/drugs\/800024045 (accessed 2018-12-29)."},{"key":"ref95\/cit95","doi-asserted-by":"publisher","DOI":"10.1186\/2050-6511-14-7"},{"key":"ref96\/cit96","doi-asserted-by":"publisher","DOI":"10.4103\/0974-9233.173134"},{"key":"ref97\/cit97","unstructured":"Trimetazidine; DrugBank, 2019; https:\/\/www.drugbank.ca\/drugs\/DB09069\/ (accessed May 12, 2019)."},{"key":"ref98\/cit98","first-page":"69","author":"Chiou G.","year":"2012","journal-title":"Retina Today"},{"key":"ref99\/cit99","unstructured":"Jaffe, G. J.; Tao, W. A. A phase 2 study of encapsulated CNTF-secreting cell implant (NT-501) in patients with geographic atrophy associated with dry AMD-18-month. Presented at theAssociation for Research in Vision and Ophthalmology Annual Meeting, May 2005, Fort Lauderdale, FL, 2005."},{"key":"ref100\/cit100","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2008.02.008"},{"key":"ref101\/cit101","unstructured":"Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration.ClinicalTrials.gov; National Institutes of Heath: Bethesda, MD, 2017; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01342926."},{"key":"ref102\/cit102","unstructured":"AKST4290: Targeting Eotaxin\u2014Alkahest; Alkahest, 2020; https:\/\/www.alkahest.com\/pipeline\/akst4290\/ (accessed 2020-01-10)."},{"key":"ref103\/cit103a","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.081224"},{"key":"ref103\/cit103b","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.10.1268"},{"key":"ref103\/cit103c","unstructured":"cWhat Is Glaucoma?; American Academy of Ophthalmology, 2019; https:\/\/www.aao.org\/eye-health\/diseases\/what-is-glaucoma\/ (accessed 2019-03-15)."},{"key":"ref104\/cit104","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804630"},{"key":"ref105\/cit105a","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61423-7"},{"key":"ref105\/cit105b","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2016.03.038"},{"key":"ref106\/cit106","unstructured":"Diagnosis and Treatment of Normal-Tension Glaucoma; American Academy of Ophthalmology, 2019; https:\/\/www.aao.org\/eyenet\/article\/diagnosis-treatment-of-normal-tension-glaucoma\/ (accessed 2019-01-21)."},{"key":"ref107\/cit107","unstructured":"Secondary Glaucoma; Glaucoma Research Foundation, San Francisco, 2017; https:\/\/www.glaucoma.org\/glaucoma\/secondary-glaucoma.php\/ (accessed 2019-03-12)."},{"key":"ref108\/cit108","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2011.11.002"},{"key":"ref109\/cit109","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00828"},{"key":"ref110\/cit110a","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(98)00272-4"},{"key":"ref110\/cit110b","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31469-1"},{"key":"ref111\/cit111a","unstructured":"aGlaucoma: Symptoms, Treatment and Prevention; All About Vision, 2019; https:\/\/www.allaboutvision.com\/conditions\/glaucoma.htm\/ (accessed 2019-01-12)."},{"key":"ref111\/cit111b","unstructured":"bEyedrop Medicine for Glaucoma; American Academy of Ophthalmology, 2019; https:\/\/www.aao.org\/eye-health\/diseases\/glaucoma-eyedrop-medicine\/ (accessed 2019-01-19)."},{"key":"ref111\/cit111c","doi-asserted-by":"publisher","DOI":"10.2298\/SARH1510626B"},{"key":"ref112\/cit112a","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.7.957"},{"key":"ref112\/cit112b","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.83.6.718"},{"key":"ref112\/cit112c","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200102000-00011"},{"key":"ref112\/cit112d","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S25636"},{"key":"ref113\/cit113a","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)72725-4"},{"key":"ref113\/cit113b","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2014.06.006"},{"key":"ref113\/cit113c","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2013.267"},{"key":"ref114\/cit114","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.10.026"},{"key":"ref115\/cit115a","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6700148"},{"key":"ref115\/cit115b","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.11.1228"},{"key":"ref115\/cit115c","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.03.028"},{"key":"ref115\/cit115d","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200102000-00011"},{"key":"ref116\/cit116a","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.10.049"},{"key":"ref116\/cit116b","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-7020-5193-7.00072-8"},{"key":"ref117\/cit117","unstructured":"Glaucoma; Mayo Clinic: Rochester, MN, 2018; https:\/\/www.mayoclinic.org\/diseases-conditions\/glaucoma\/diagnosis-treatment\/drc-20372846\/ (accessed 2019-02-21)."},{"key":"ref118\/cit118","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(01)00912-6"},{"key":"ref119\/cit119","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01974-7"},{"key":"ref120\/cit120","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00143-0"},{"key":"ref121\/cit121","series-title":"WGA Consensus Series","volume-title":"Medical Treatment of Glaucoma","author":"Weinreb R. N.","year":"2010"},{"key":"ref122\/cit122","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.10.1405"},{"key":"ref123\/cit123","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(96)00811-3"},{"key":"ref124\/cit124a","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2013.2100"},{"key":"ref124\/cit124b","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S41000"},{"key":"ref124\/cit124c","doi-asserted-by":"publisher","DOI":"10.4161\/sgtp.29770"},{"key":"ref124\/cit124d","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1128"},{"key":"ref124\/cit124e","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-018-0566-9"},{"key":"ref124\/cit124f","first-page":"163","volume":"13","author":"Ali M.","year":"2017","journal-title":"Al-Shifa J. Ophthalmol."},{"key":"ref125\/cit125a","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2007.76"},{"key":"ref125\/cit125b","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12641"},{"key":"ref126\/cit126","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2005.06.003"},{"key":"ref127\/cit127","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0333-2"},{"key":"ref128\/cit128","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2010.11.060"},{"key":"ref129\/cit129","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2013.09.010"},{"key":"ref130\/cit130","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.12.012"},{"key":"ref131\/cit131","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2014.03.017"},{"key":"ref132\/cit132","doi-asserted-by":"publisher","DOI":"10.1021\/jm800986w"},{"key":"ref133\/cit133","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.09.040"},{"key":"ref134\/cit134","first-page":"3867","volume":"53","author":"deLong M. A.","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref135\/cit135","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.04.040"},{"key":"ref136\/cit136","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01130-z"},{"key":"ref137\/cit137","first-page":"5080","volume":"53","author":"Kopczynski C.","year":"2012","journal-title":"Ophthalmol. Vis. Sci."},{"key":"ref138\/cit138","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e3182952213"},{"key":"ref139\/cit139","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2016.04.002"},{"key":"ref140\/cit140","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2017.0023"},{"key":"ref141\/cit141","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20189"},{"key":"ref142\/cit142","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.08.022"},{"key":"ref143\/cit143a","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.11.019"},{"key":"ref143\/cit143b","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2015.01.026"},{"key":"ref144\/cit144a","unstructured":"aAerie Pharmaceuticals Reports Positive RoclatanTM (Netarsudil\/Latanoprost Ophthalmic Solution) 0.02%\/0.005% Phase 3 Topline Efficacy Results; Business Wire, 2019; https:\/\/www.businesswire.com\/news\/home\/20170524006043\/en\/Aerie-Pharmaceuticals-Reports-Positive-Roclatan%E2%84%A2-netarsudillatanoprost-ophthalmic\/ (accessed Aug 18, 2019)."},{"key":"ref144\/cit144b","first-page":"E351","author":"Bacharach J.","year":"2017","journal-title":"Am. Acad. Optom. Abst."},{"key":"ref145\/cit145","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-306778"},{"key":"ref146\/cit146","unstructured":"RoclatanTM Mercury 2 Phase 3 Topline Results; Aerie Pharmaceuticals Inc, 2016; http:\/\/investors.aeriepharma.com\/static-files\/fb9a0c3f-7255-4b50-97b2-450a2ba5d139\/ (accessed Sep 14, 2019)."},{"key":"ref147\/cit147a","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-1617"},{"key":"ref147\/cit147b","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2008.0142"},{"key":"ref148\/cit148","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2007.76"},{"key":"ref149\/cit149","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12641"},{"key":"ref150\/cit150","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-302466"},{"key":"ref151\/cit151","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.04.012"},{"key":"ref152\/cit152","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.04.040"},{"key":"ref153\/cit153","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0333-2"},{"key":"ref154\/cit154a","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2013.323"},{"key":"ref154\/cit154b","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12599"},{"key":"ref155\/cit155","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2013.05.016"},{"key":"ref156\/cit156","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2015.0525"},{"key":"ref157\/cit157","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12829"},{"key":"ref158\/cit158","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2016.1250276"},{"key":"ref159\/cit159","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-016-0427-9"},{"key":"ref160\/cit160a","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000000552"},{"key":"ref160\/cit160b","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-017-3727-5"},{"key":"ref161\/cit161","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0389-3"},{"key":"ref162\/cit162","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2016.0085"},{"key":"ref163\/cit163","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185305"},{"key":"ref164\/cit164","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-13842"},{"key":"ref165\/cit165a","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2013.01.005"},{"key":"ref165\/cit165b","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2017.50.2.200"},{"key":"ref166\/cit166a","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S15971"},{"key":"ref166\/cit166b","unstructured":"INO-8875; Inotek Pharmaceuticals, 2019; http:\/\/www.inotekcorp.com\/content\/ino-8875.asp (accessed 2019-01-19)."},{"key":"ref167\/cit167a","first-page":"527","volume":"53","author":"Fredholm B. B.","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"ref167\/cit167b","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1983"},{"key":"ref168\/cit168","first-page":"287","volume":"267","author":"Webb R. L.","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref169\/cit169","unstructured":"Phase 1\/2 Clinical Trial for OPA-6566, 2019; https:\/\/adisinsight.springer.com\/drugs\/800032852 (accessed 2019-01-21)."},{"key":"ref170\/cit170","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2009.0120"},{"key":"ref171\/cit171a","doi-asserted-by":"publisher","DOI":"10.1002\/med.2610140103"},{"key":"ref171\/cit171b","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(98)00092-6"},{"key":"ref172\/cit172a","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-14515"},{"key":"ref172\/cit172b","doi-asserted-by":"publisher","DOI":"10.1089\/10807680151125555"},{"key":"ref172\/cit172c","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(94)90157-0"},{"key":"ref173\/cit173","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-017-0094-6"},{"key":"ref174\/cit174a","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12298"},{"key":"ref174\/cit174b","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2007.01167.x"},{"key":"ref175\/cit175","unstructured":"Nitric Oxide (NO)-Donors: The Nicox Expertise; Nicox, 2019; http:\/\/www.nicox.com\/rd\/ (accessed 2019-08-21)."},{"key":"ref176\/cit176","unstructured":"Product and Product Candidates; Nicox, 2020 https:\/\/www.nicox.com\/rd\/#!\/candidates\/ (accessed 2020-01-21)."},{"key":"ref177\/cit177a","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2011.03.001"},{"key":"ref177\/cit177","unstructured":"Vyzulta for Patients with Glaucoma; Bausch & Lomb Incorporated, 2018; https:\/\/www.vyzulta.com\/ (accessed 2019-08)."},{"key":"ref178\/cit178","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-16015"},{"key":"ref179\/cit179","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S103985"},{"key":"ref180\/cit180","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-17190"},{"key":"ref181\/cit181","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2011.03.001"},{"key":"ref182\/cit182","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-015-0260-y"},{"key":"ref183\/cit183","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305908"},{"key":"ref184\/cit184","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2016.04.019"},{"key":"ref185\/cit185","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.01.019"},{"key":"ref186\/cit186","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2016.05.012"},{"key":"ref187\/cit187","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0385-7"},{"key":"ref188\/cit188","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2009.0120"},{"key":"ref189\/cit189","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2011.02.006"},{"key":"ref190\/cit190","unstructured":"Pipeline of Ophthalmic Therapeutics; Nicox, 2020; https:\/\/www.nicox.com\/rd\/#!\/candidates\/ (accessed 2020-01-21)."},{"key":"ref191\/cit191","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-17190"},{"key":"ref192\/cit192a","unstructured":"aNews; Nicox, 2020; https:\/\/www.nicox.com\/news-media\/news\/#2019\/ (accessed 2020-01-10)."},{"key":"ref192\/cit192b","unstructured":"bNicox Presents First Data on Promising New Class of Nitric Oxide (NO)-Donating Compounds for Glaucoma at the ARVO 2019 Annual Meeting; Nicox, 2019; https:\/\/www.nicox.com\/news-media\/presents-first-data-on-promising-new-class-of-nitric-oxide-no-donating-compounds-for-glaucoma-at-the-arvo-2019-annual-meeting\/ (accessed 2020-01-10)."},{"key":"ref193\/cit193a","unstructured":"aNicox Announces the Presentation of NCX 667 Scientific Data at AOPT 2017; Nicox, 2017; https:\/\/www.marketscreener.com\/NICOX-25281955\/news\/Nicox-announces-the-presentation-of-NCX-667-scientific-data-at-AOPT-2017-23911286\/ (accessed 2020-01-10)."},{"key":"ref193\/cit193b","unstructured":"bNCX 667, A Novel Nitric Oxide (NO) Donor, Effectively Reduces Intraocular Pressure (IOP) in Three Models of Ocular Hypertension and Glaucoma, 2020; https:\/\/congresso.sifweb.org\/archivio\/cong37\/abs\/650.pdf\/ (accessed 2020-01-10)."},{"key":"ref194\/cit194","unstructured":"NCX 1741, A Novel NO-donating Derivative of the Phosphodiesterase-5 Inhibitor Avanafil, Reduces IOP in Models of Ocular Hypertension and Glaucoma; Nicox, 2020; https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2743508 (accessed 2020-01-10)."},{"key":"ref195\/cit195","doi-asserted-by":"publisher","DOI":"10.1038\/31729"},{"key":"ref196\/cit196","doi-asserted-by":"publisher","DOI":"10.1021\/jm901226j"},{"key":"ref197\/cit197","doi-asserted-by":"publisher","DOI":"10.1021\/ml500367g"},{"key":"ref198\/cit198a","doi-asserted-by":"publisher","DOI":"10.1021\/jm401431x"},{"key":"ref198\/cit198b","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R600038200"},{"key":"ref198\/cit198c","first-page":"4107","volume":"43","author":"Krauss A. H.","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref199\/cit199","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00808"},{"key":"ref200\/cit200a","unstructured":"Diabetic Retinopathy; Diabetes.co.uk, 2019; https:\/\/www.diabetes.co.uk\/diabetes-complications\/diabetic-retinopathy.html\/ (accessed 2019-01-31)."},{"key":"ref200\/cit200b","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-S003"},{"key":"ref201\/cit201","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93751"},{"key":"ref202\/cit202","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2015.08.001"},{"key":"ref203\/cit203a","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2011.3906"},{"key":"ref203\/cit203b","doi-asserted-by":"publisher","DOI":"10.1186\/2045-3701-4-27"},{"key":"ref204\/cit204a","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2156273"},{"key":"ref204\/cit204","unstructured":"Diabetic Retinopathy; Mayo Clinic: Rochester, MN, 2018; https:\/\/www.mayoclinic.org\/diseases-conditions\/diabetic-retinopathy\/symptoms-causes\/syc-20371611\/\/ (accessed 2019-02-21)."},{"key":"ref205\/cit205a","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.6.1615"},{"key":"ref205\/cit205b","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/343560"},{"key":"ref206\/cit206","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-8727(01)00155-6"},{"key":"ref207\/cit207a","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-21355"},{"key":"ref207\/cit207b","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1655-6"},{"key":"ref208\/cit208a","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.01.031"},{"key":"ref208\/cit208b","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.02.045"},{"key":"ref208\/cit208c","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.07.032"},{"key":"ref208\/cit208d","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414264"},{"key":"ref209\/cit209a","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.02.031"},{"key":"ref209\/cit209b","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2016.10.10"},{"key":"ref210\/cit210a","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20161004-04"},{"key":"ref210\/cit210b","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.04.025"},{"key":"ref210\/cit210c","unstructured":"cAnti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema (RUBY).ClinicalTrials.gov; National Insitutes of Health: Bethesda, MD, 2018; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02712008\/ (accessed 2020-01-05)."},{"key":"ref210\/cit210d","unstructured":"dA Study of Faricimab (RO6867461) in Participants With Center-involving Diabetic Macular Edema (BOULEVARD).ClinicalTrials.gov; National Insitutes of Health: Bethesda, MD, 2019; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02699450\/ (accesed Jan 5, 2020)."},{"key":"ref211\/cit211a","unstructured":"aSafety Study of Intravitreal EBI-031 Given as a Single or Repeat Injection to Subjects with Diabetic Macular Edema;ClinicalTrials.gov; National Insitutes of Health: Bethesda, MD, 2016; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02842541\/ (accesssed Jan 20, 2019)."},{"key":"ref211\/cit211b","unstructured":"bRanibizumab for Edema of the Macula in Diabetes: Protocol 4 with Tocilizumab: the read-4 Study;ClinicalTrials.gov; National Insitutes of Health: Bethesda, MD, 2018; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02511067\/ (accessed 2019-01-20)."},{"key":"ref212\/cit212a","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(87)33527-4"},{"key":"ref212\/cit212b","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(78)35693-1"},{"key":"ref213\/cit213a","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200603000-00024"},{"key":"ref213\/cit213b","doi-asserted-by":"publisher","DOI":"10.2174\/09298673113209990030"},{"key":"ref213\/cit213c","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S38559"},{"key":"ref214\/cit214a","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2009.03.012"},{"key":"ref214\/cit214b","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.020248"},{"key":"ref214\/cit214c","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/131538"},{"key":"ref215\/cit215a","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-2310"},{"key":"ref215\/cit215b","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10007"},{"key":"ref215\/cit215c","doi-asserted-by":"publisher","DOI":"10.2337\/db11-0026"},{"key":"ref215\/cit215d","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1514213113"},{"key":"ref216\/cit216","unstructured":"KalVista for DME; KalVista Pharmaceuticals, 2020; https:\/\/www.kalvista.com\/products-pipeline\/kalvista-dme\/ (accessed 2020-03-20)."},{"key":"ref217\/cit217","first-page":"3464","volume":"59","author":"Murugesan N.","year":"2018","journal-title":"Invest. Ophthal. Vis. Sc."},{"key":"ref218\/cit218","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1723078"},{"key":"ref219\/cit219","unstructured":"Novel Oral Plasma Kallikrein (PKa) Inhibitors KV998052 and KV998054 Ameliorate VEGF-Induced Retinal Thickening in a Murine Model of Retinal Edema; KalVista, 2019; https:\/\/www.kalvista.com\/healthcare-providers\/publications\/ (accesed 2020-03-15)."},{"key":"ref220\/cit220","unstructured":"KalVista Pharmaceuticals Announces Collaboration with Merck; Business Wire, 2017; https:\/\/www.businesswire.com\/news\/home\/20171010005129\/en\/KalVista-Pharmaceuticals-Announces-Collaboration-Merck\/ (accessed 2020-03-20)."},{"key":"ref221\/cit221","unstructured":"KalVista Plans to Continue Work on Diabetic Macular Edema After Merck Walks Away from Deal; BioSpace, 2020; https:\/\/www.biospace.com\/article\/merck-walks-away-from-kalvista-option-deal\/ (accessed 2020-03-20)."},{"key":"ref222\/cit222","unstructured":"Oxurion NV Reports Additional Positive Topline Data from Phase 1 with THR-149, a Novel, Potent Plasma Kallikrein Inhibitor for DME; Global Newswire, 2019; https:\/\/www.globenewswire.com\/news-release\/2019\/09\/09\/1912924\/0\/en\/Oxurion-NV-Reports-Additional-Positive-Topline-Data-from-Phase-1-with-THR-149-a-Novel-Potent-Plasma-Kallikrein-Inhibitor-for-DME.html\/ (accessed 2020-03-20)."},{"key":"ref223\/cit223","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.117663"},{"key":"ref224\/cit224","first-page":"3576","volume":"59","author":"Calton M. A.","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref225\/cit225a","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-0124(12)70082-4"},{"key":"ref225\/cit225b","unstructured":"bFacts About Dry Eye; National Eye Institute: Bethesda, MD, 2019; https:\/\/nei.nih.gov\/health\/dryeye\/dryeye\/ (accessed 2019-01-29)."},{"key":"ref225\/cit225c","first-page":"240","volume":"9","author":"Hessen A. W.","year":"2014","journal-title":"J. Ophthalmic Vis. Res."},{"key":"ref226\/cit226a","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-0124(12)70081-2"},{"key":"ref226\/cit226b","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1407936"},{"key":"ref226\/cit226c","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X26252"},{"key":"ref226\/cit226d","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2014.915026"},{"key":"ref226\/cit226e","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2015.10.001"},{"key":"ref226\/cit226f","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2014.4893"},{"key":"ref227\/cit227a","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)00176-1"},{"key":"ref227\/cit227b","unstructured":"bFDA Approves New Medication for Dry Eye Disease; US Food and Drug Administration, 2017; https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-medication-dry-eye-disease\/ (accessed 2019-02-21)."},{"key":"ref228\/cit228","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-13881"},{"key":"ref229\/cit229","unstructured":"Meibomian Gland Dysfunction (MGD); American Academy of Ophthalmology, 2019; https:\/\/eyewiki.aao.org\/Meibomian_Gland_Dysfunction_(MGD) (accessed 2019-01-20)."},{"key":"ref230\/cit230","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.84.1.76"},{"key":"ref231\/cit231","doi-asserted-by":"publisher","DOI":"10.1177\/2515841419870366"},{"key":"ref232\/cit232a","unstructured":"aFacts About Cataract; National Eye Institute: Bethesda, MD, 2019; https:\/\/nei.nih.gov\/health\/cataract\/cataract_facts\/ (accessed Jan 21, 2019)."},{"key":"ref232\/cit232b","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e328341425d"},{"key":"ref232\/cit232c","unstructured":"cPriority Eye Diseases; World Health Organization, 2019; http:\/\/www9.who.int\/blindness\/causes\/priority\/en\/ (accessed 2019-04-31)."},{"key":"ref233\/cit233a","doi-asserted-by":"publisher","DOI":"10.1177\/112067219900900211"},{"key":"ref233\/cit233b","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMicm1507349"},{"key":"ref233\/cit233c","doi-asserted-by":"publisher","DOI":"10.1159\/000072039"},{"key":"ref234\/cit234a","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3181f7f363"},{"key":"ref234\/cit234b","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.75.3.193"},{"key":"ref234\/cit234c","doi-asserted-by":"publisher","DOI":"10.12816\/0042978"},{"key":"ref235\/cit235","first-page":"58","volume":"113","author":"Davis G.","year":"2016","journal-title":"Mol. Med."},{"key":"ref236\/cit236","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30544-5"},{"key":"ref237\/cit237a","first-page":"36","volume":"17","author":"Eisenberg J. S.","year":"2013","journal-title":"Ophthalmol. Manage."},{"key":"ref237\/cit237b","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2015.04.005"},{"key":"ref238\/cit238a","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000016"},{"key":"ref238\/cit238b","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2015.12.005"},{"key":"ref239\/cit239","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/B978-0-323-03938-3.50184-6","volume-title":"Decision Making in Anesthesiology: An Algorithm Approach","author":"Mcgoldrick K. E.","year":"2007","edition":"4"},{"key":"ref240\/cit240a","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.83.9.1036"},{"key":"ref240\/cit240b","first-page":"34","author":"Alezzandrini A.","year":"2010","journal-title":"Retina Today"},{"key":"ref241\/cit241","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4106893"},{"key":"ref242\/cit242","doi-asserted-by":"publisher","DOI":"10.1016\/j.optom.2016.06.002"},{"key":"ref243\/cit243","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)70803-5"},{"key":"ref244\/cit244","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2018.12.025"},{"key":"ref245\/cit245","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-018-04218-6"},{"key":"ref246\/cit246","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2015.04.005"},{"key":"ref247\/cit247","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000016"},{"key":"ref248\/cit248","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14096"},{"key":"ref249\/cit249","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2013.09.002"},{"key":"ref250\/cit250","first-page":"45","volume":"3","author":"Karahan E.","year":"2014","journal-title":"Med. Hypothesis Discovery Innov. Ophthalmol."},{"key":"ref251\/cit251","doi-asserted-by":"publisher","DOI":"10.4102\/phcfm.v4i1.412"},{"key":"ref252\/cit252","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.85.7.776"},{"key":"ref253\/cit253","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2007.09.016"},{"key":"ref254\/cit254","doi-asserted-by":"publisher","DOI":"10.4102\/aveh.v69i4.143"},{"key":"ref255\/cit255","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4103\/1119-3077.212451","volume":"20","author":"Fadamiro C.","year":"2017","journal-title":"Nig. J. Clin. Prac."},{"key":"ref256\/cit256","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2010.07.291"},{"key":"ref257\/cit257","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac9145"},{"key":"ref258\/cit258","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.18-25647"},{"key":"ref259\/cit259","unstructured":"New Drugs You May Have Missed.Review of Cornea and Contact Lenses2014, https:\/\/www.reviewofcontactlenses.com\/article\/new-drugs-you-may-have-missed\/ (accessed 2020-03-20)."},{"key":"ref260\/cit260","doi-asserted-by":"publisher","DOI":"10.1021\/jm200256g"},{"key":"ref261\/cit261","doi-asserted-by":"publisher","DOI":"10.1021\/jm5010013"},{"key":"ref262\/cit262","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2014.04.089"},{"key":"ref263\/cit263","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7933"},{"key":"ref264\/cit264","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.8b00104"},{"key":"ref265\/cit265","doi-asserted-by":"publisher","DOI":"10.1021\/ml300005w"},{"key":"ref266\/cit266","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b01227"},{"key":"ref267\/cit267","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01731"},{"key":"ref268\/cit268","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00449"},{"key":"ref269\/cit269","doi-asserted-by":"publisher","DOI":"10.1021\/jm7011276"},{"key":"ref270\/cit270","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b01039"},{"key":"ref271\/cit271","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200312000-00010"},{"key":"ref272\/cit272","doi-asserted-by":"publisher","DOI":"10.1021\/jm101501b"},{"key":"ref273\/cit273","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2009.06.002"},{"key":"ref274\/cit274","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm007"},{"key":"ref275\/cit275a","doi-asserted-by":"publisher","DOI":"10.1039\/C5CC02215K"},{"key":"ref275\/cit275b","doi-asserted-by":"publisher","DOI":"10.1021\/jm301488q"},{"key":"ref276\/cit276","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00971"},{"key":"ref277\/cit277","doi-asserted-by":"publisher","DOI":"10.1021\/jm901381j"},{"key":"ref278\/cit278","doi-asserted-by":"publisher","DOI":"10.1021\/np300769c"},{"key":"ref279\/cit279","doi-asserted-by":"publisher","DOI":"10.1016\/j.dyepig.2013.06.037"},{"key":"ref280\/cit280","doi-asserted-by":"publisher","DOI":"10.1021\/jm300031j"},{"key":"ref281\/cit281","doi-asserted-by":"publisher","DOI":"10.1021\/jm400414j"},{"key":"ref282\/cit282","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00462"},{"key":"ref283\/cit283","doi-asserted-by":"publisher","DOI":"10.1021\/jm501497m"},{"key":"ref284\/cit284","doi-asserted-by":"publisher","DOI":"10.1021\/jm501314c"},{"key":"ref285\/cit285","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00383"},{"key":"ref286\/cit286","doi-asserted-by":"publisher","DOI":"10.1021\/jm060967z"},{"key":"ref287\/cit287","doi-asserted-by":"publisher","DOI":"10.1021\/jm101541x"},{"key":"ref288\/cit288","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b01389"},{"key":"ref289\/cit289","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00043"},{"key":"ref290\/cit290","doi-asserted-by":"publisher","DOI":"10.1021\/jm400062r"},{"key":"ref291\/cit291","doi-asserted-by":"publisher","DOI":"10.1021\/jm100579r"},{"key":"ref292\/cit292","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2010.04.070"},{"key":"ref293\/cit293","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.110635"},{"key":"ref294\/cit294","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2010.07.014"},{"key":"ref295\/cit295","doi-asserted-by":"publisher","DOI":"10.1021\/jm201289r"},{"key":"ref296\/cit296","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2008.10.080"},{"key":"ref297\/cit297","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.09.040"},{"key":"ref298\/cit298","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.7b00264"},{"key":"ref299\/cit299","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00007"},{"key":"ref300\/cit300a","doi-asserted-by":"publisher","DOI":"10.1021\/jm050663x"},{"key":"ref300\/cit300b","doi-asserted-by":"publisher","DOI":"10.1021\/jm030205t"},{"key":"ref301\/cit301","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00857"},{"key":"ref302\/cit302","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27516-9"},{"key":"ref303\/cit303","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jnatprod.6b00185"},{"key":"ref304\/cit304","doi-asserted-by":"publisher","DOI":"10.1021\/jm050382p"},{"key":"ref305\/cit305","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01625"},{"key":"ref306\/cit306a","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2012.12.025"},{"key":"ref306\/cit306b","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2013.04.011"},{"key":"ref307\/cit307","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.7b05063"},{"key":"ref308\/cit308","doi-asserted-by":"publisher","DOI":"10.1021\/jm900350f"},{"key":"ref309\/cit309","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201500180"},{"key":"ref310\/cit310","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b01792"},{"key":"ref311\/cit311","doi-asserted-by":"publisher","DOI":"10.1002\/jps.10470"},{"key":"ref312\/cit312","doi-asserted-by":"publisher","DOI":"10.1021\/jm2001986"},{"key":"ref313\/cit313","doi-asserted-by":"publisher","DOI":"10.1021\/ja303931b"},{"key":"ref314\/cit314","doi-asserted-by":"publisher","DOI":"10.1039\/c3pp50118c"},{"key":"ref315\/cit315a","doi-asserted-by":"publisher","DOI":"10.5497\/wjp.v2.i2.47"},{"key":"ref315\/cit315b","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2014.10.006"},{"key":"ref315\/cit315c","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.06.043"},{"key":"ref316\/cit316","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2005.09.049"},{"key":"ref317\/cit317","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2013.09.002"},{"key":"ref318\/cit318","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2006.22.333"},{"key":"ref319\/cit319","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(98)00055-6"},{"key":"ref320\/cit320","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600721109"},{"key":"ref321\/cit321","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S139436"},{"key":"ref322\/cit322","first-page":"684","volume":"30","author":"Huang A.","year":"1989","journal-title":"Invest. Ophth. Vis. Sc."},{"key":"ref323\/cit323","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(99)80096-8"},{"key":"ref324\/cit324","doi-asserted-by":"publisher","DOI":"10.1089\/108076802321021108"},{"key":"ref325\/cit325","doi-asserted-by":"publisher","DOI":"10.1016\/S1350-9462(01)00018-0"},{"key":"ref326\/cit326","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4835(77)90136-1"},{"key":"ref327\/cit327","first-page":"1181","volume":"41","author":"Ambati J.","year":"2000","journal-title":"Invest. Ophthal. Vis. Sci."},{"key":"ref328\/cit328","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24465"},{"key":"ref329\/cit329","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(99)00239-1"},{"key":"ref330\/cit330","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-1027"},{"key":"ref331\/cit331","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4835(85)90138-1"},{"key":"ref332\/cit332","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60761-938-3_5"},{"key":"ref333\/cit333","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.10.3107"},{"key":"ref334\/cit334","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2007.10.013"},{"key":"ref335\/cit335","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-1051"},{"key":"ref336\/cit336a","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-010-9183-3"},{"key":"ref336\/cit336b","first-page":"961","volume":"41","author":"Geroski D. H.","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref336\/cit336c","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2005.01.009"},{"key":"ref337\/cit337a","doi-asserted-by":"publisher","DOI":"10.4155\/bio.10.2"},{"key":"ref337\/cit337b","doi-asserted-by":"publisher","DOI":"10.1081\/DDC-120003445"},{"key":"ref337\/cit337c","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21200"},{"key":"ref338\/cit338a","first-page":"1950","volume":"31","author":"She S. C.","year":"1990","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref338\/cit338b","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2008.05.034"},{"key":"ref338\/cit338c","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2014.10.010"},{"key":"ref339\/cit339a","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.3.1.45"},{"key":"ref339\/cit339b","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e3281108000"},{"key":"ref339\/cit339c","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.07.036"},{"key":"ref340\/cit340a","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200002000-00014"},{"key":"ref340\/cit340b","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.01.030"},{"key":"ref341\/cit341a","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.1.1.99"},{"key":"ref341\/cit341b","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.4.4.371"},{"key":"ref341\/cit341c","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-0670"},{"key":"ref342\/cit342","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.28.1"},{"key":"ref343\/cit343","doi-asserted-by":"publisher","DOI":"10.1002\/cne.903400409"},{"key":"ref344\/cit344","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22610"},{"key":"ref345\/cit345","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S118409"},{"key":"ref346\/cit346","first-page":"HS19","volume":"40","author":"Dellabella A.","year":"2015","journal-title":"US Pharm."},{"key":"ref347\/cit347","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1977.04450080088009"},{"key":"ref348\/cit348","doi-asserted-by":"publisher","DOI":"10.1088\/0957-4484\/20\/50\/505101"},{"key":"ref349\/cit349b","doi-asserted-by":"publisher","DOI":"10.5650\/jos.59.423"},{"key":"ref350\/cit350","doi-asserted-by":"publisher","DOI":"10.18433\/J3DP43"},{"key":"ref351\/cit351a","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2016.1201059"},{"key":"ref351\/cit351b","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2017.11.046"},{"key":"ref351\/cit351c","doi-asserted-by":"publisher","DOI":"10.3390\/md15120370"},{"key":"ref351\/cit351d","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.09.017"},{"key":"ref351\/cit351e","doi-asserted-by":"publisher","DOI":"10.2174\/1381612821666150923095155"},{"key":"ref351\/cit351f","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2017.04.001"},{"key":"ref352\/cit352a","doi-asserted-by":"publisher","DOI":"10.1021\/nn4046024"},{"key":"ref352\/cit352b","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2015.02.019"},{"key":"ref353\/cit353a","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2003.09.016"},{"key":"ref353\/cit353b","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0108076"},{"key":"ref353\/cit353c","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S65601"},{"key":"ref354\/cit354","doi-asserted-by":"publisher","DOI":"10.1208\/aapsj0903044"},{"key":"ref355\/cit355","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181a2f42a"},{"key":"ref356\/cit356","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2007.10.021"},{"key":"ref357\/cit357","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11020055"},{"key":"ref358\/cit358","first-page":"213","volume":"2","author":"Mukherjee B.","year":"2007","journal-title":"Int. J. Nanomed."},{"key":"ref359\/cit359","first-page":"466","volume":"53","author":"Vyas S. P.","year":"1998","journal-title":"Pharmazie"},{"key":"ref360\/cit360","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2004.10.026"},{"key":"ref361\/cit361","doi-asserted-by":"publisher","DOI":"10.1081\/DDC-120002997"},{"key":"ref362\/cit362a","doi-asserted-by":"publisher","DOI":"10.3109\/08982104.2014.881850"},{"key":"ref362\/cit362b","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22422"},{"key":"ref363\/cit363a","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-008-9105-1"},{"key":"ref363\/cit363b","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2006.07.022"},{"key":"ref364\/cit364","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.103"},{"key":"ref365\/cit365","unstructured":"Novelia\u00ae, 2015; https:\/\/www.nemera.net\/products\/ophthalmic\/novelia\/ (accessed 2019-01-21)."},{"key":"ref366\/cit366a","unstructured":"aIntroducing Ocusurf Nanostructured Emulsion as a 505(B)(2) Strategy; On Drug Delivery: Lewes, UK, 2016; https:\/\/www.ondrugdelivery.com\/introducing-ocusurf-nanostructured-emulsion-505b2-strategy\/ (accessed 2019-02-21)."},{"key":"ref366\/cit366b","doi-asserted-by":"publisher","DOI":"10.4155\/tde.10.40"},{"key":"ref367\/cit367","unstructured":"Ophthalmic Drug Delivery; On Drug Delivery: Lewes, UK, 2020; https:\/\/www.ondrugdelivery.com\/publications\/63\/emultech.pdf\/ (accessed 2019-01-21)."},{"key":"ref368\/cit368a","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199345060-00007"},{"key":"ref368\/cit368b","unstructured":"bOpsisporin: A Long Acting Drug Delivery Approach.MidaTech Pharma; On Drug Delivery: Lewes, UK, 2016; https:\/\/pdfs.semanticscholar.org\/30f3\/4f4261c25f00edab736c69463dacae1bdc91.pdf\/ (accessed 2019-05-21)."},{"key":"ref369\/cit369","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.01.012"},{"key":"ref370\/cit370","doi-asserted-by":"publisher","DOI":"10.1021\/nn506599f"},{"key":"ref371\/cit371a","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06981-w"},{"key":"ref371\/cit371b","doi-asserted-by":"publisher","DOI":"10.17925\/USOR.2011.04.02.107"},{"key":"ref372\/cit372","unstructured":"INVELTYS (Loteprednol Etabonate Ophthalmic Suspension) 1%; Kala Pharmaceuticals, 2019; https:\/\/inveltys.com\/ (accessed 2020-03-20)."},{"key":"ref373\/cit373","unstructured":"Dextenza; Ocular Therapeutix: Bedford, MA, 2020; https:\/\/www.ocutx.com\/products\/dextenza\/ (accessed 2020-03-20)."},{"key":"ref374\/cit374a","doi-asserted-by":"publisher","DOI":"10.3109\/08820538.2014.889179"},{"key":"ref374\/cit374b","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-011-0019-z"},{"key":"ref375\/cit375","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.04.024"},{"key":"ref376\/cit376","unstructured":"OZURDEX (Dexamethasone Intravitreal Implant), 2020; http:\/\/www.ozurdex.com\/ (accessed Jan10, 2020)."},{"key":"ref377\/cit377a","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000787"},{"key":"ref377\/cit377b","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2018.01.14"},{"key":"ref377\/cit377c","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002196"},{"key":"ref378\/cit378","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2019.1652449"},{"key":"ref379\/cit379","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2018.1501492"},{"key":"ref380\/cit380a","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000515"},{"key":"ref380\/cit380b","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.04.012"},{"key":"ref380\/cit380c","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2013.11.014"},{"key":"ref381\/cit381","doi-asserted-by":"publisher","DOI":"10.3109\/15569527.2014.975242"},{"key":"ref382\/cit382","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-018-0905-0"},{"key":"ref383\/cit383","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10028-1226"},{"key":"ref384\/cit384","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfo.2015.03.002"},{"key":"ref385\/cit385","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0616-7"},{"key":"ref386\/cit386","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3466.2004.tb00134.x"},{"key":"ref387\/cit387a","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(02)00327-2"},{"key":"ref387\/cit387b","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2005.10.045"},{"key":"ref388\/cit388","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.158071"},{"key":"ref389\/cit389","doi-asserted-by":"publisher","DOI":"10.3109\/10717544.2016.1138342"},{"key":"ref390\/cit390a","first-page":"17","volume":"1","author":"Maulvi F. A.","year":"2014","journal-title":"J. Pharm. Appl. Sci."},{"key":"ref390\/cit390b","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.01.023"},{"key":"ref390\/cit390c","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2012.0212"},{"key":"ref391\/cit391","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.101330"},{"key":"ref392\/cit392","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2019.05.015"},{"key":"ref393\/cit393","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-010-0159-x"},{"key":"ref394\/cit394","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2016.11.020"},{"key":"ref395\/cit395","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2018.0095"},{"key":"ref396\/cit396","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2018.0067"},{"key":"ref397\/cit397","unstructured":"U.S. FDA Accepts Allergan\u2019s New Drug Application for Bimatoprost Sustained-Release in Patients with Open-Angle Glaucoma or Ocular Hypertension; U.S. Food and Drug Administration, 2019; https:\/\/www.prnewswire.com\/news-releases\/us-fda-accepts-allergans-new-drug-application-for-bimatoprost-sustained-release-in-patients-with-open-angle-glaucoma-or-ocular-hypertension-300886238.html (accessed Dec 19, 2019)."},{"key":"ref398\/cit398a","doi-asserted-by":"publisher","DOI":"10.4172\/jbb.1000318"},{"key":"ref398\/cit398b","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.119.256933"},{"key":"ref398\/cit398c","first-page":"660","volume":"10","author":"Gote V.","year":"2019","journal-title":"EC Opthalmol."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.9b01033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T20:39:29Z","timestamp":1696192769000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jmedchem.9b01033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":530,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2020,10,8]]}},"alternative-id":["10.1021\/acs.jmedchem.9b01033"],"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01033","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]}}}